SMTL ID : 5x7d.1

Structure of beta2 adrenoceptor bound to carazolol and an intracellular allosteric antagonist

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

monomer

Ligands

2 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)

EPE.1: 7 residues within 4Å: Chain A: T.73, V.74, T.75, R.138, Y.148, Q.149, S.150 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:V.74, A:T.75, A:T.75, A:S.150 Salt bridges: A:R.138 EPE.2: 5 residues within 4Å: Chain A: F.399, K.405, K.408, R.463 Ligands: ACM.8 3 PLIP interactions: 3 interactions with chain A Salt bridges: A:K.405, A:K.408, A:R.463

2 x CLR: CHOLESTEROL(Non-covalent)

CLR.3: 4 residues within 4Å: Chain A: I.62, L.87, A.92 Ligands: CLR.4 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:I.62, A:L.87, A:A.92 CLR.4: 10 residues within 4Å: Chain A: T.80, C.84, V.88, I.119, L.122, I.161, L.162, W.165, F.173 Ligands: CLR.3 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:T.80, A:V.88, A:I.119, A:L.122, A:I.161, A:L.162, A:W.165, A:F.173

1 x 8VS: 4-carbamoyl-N-[(2R)-2-cyclohexyl-2-phenylacetyl]-L-phenylalanyl-3-bromo-N-methyl-L-phenylalaninamide(Non-covalent)

8VS.5: 16 residues within 4Å: Chain A: V.61, I.65, R.70, L.71, N.76, K.402, K.405, A.406, T.409, L.410, Y.461, R.463, S.464, P.465, D.466, F.467 22 PLIP interactions: 22 interactions with chain A Hydrophobic interactions: A:V.61, A:I.65, A:R.70, A:L.71, A:A.406, A:T.409, A:L.410, A:Y.461, A:Y.461, A:Y.461, A:D.466, A:F.467, A:F.467 Hydrogen bonds: A:R.70, A:N.76, A:N.76, A:R.463, A:S.464, A:D.466, A:D.466, A:F.467 pi-Cation interactions: A:R.70

1 x CAU: (2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol(Non-covalent)

CAU.6: 15 residues within 4Å: Chain A: W.116, D.120, V.121, F.200, Y.206, A.207, S.210, S.211, W.421, F.424, F.425, N.428, Y.443, N.447, Y.451 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:W.116, A:V.121, A:F.200, A:F.200, A:Y.206 Hydrogen bonds: A:D.120, A:S.210, A:N.447, A:N.447, A:Y.451 pi-Stacking: A:F.425

1 x BU1: 1,4-BUTANEDIOL(Non-functional Binders)

BU1.7: 6 residues within 4Å: Chain A: F.230, K.234, Y.397, K.398, F.399, H.404 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:K.234, A:F.399 Hydrogen bonds: A:F.399, A:H.404

1 x ACM: ACETAMIDE(Covalent)

ACM.8: 5 residues within 4Å: Chain A: K.398, F.399, C.400, K.405 Ligands: EPE.2 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:K.398, A:K.405

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Liu, X. et al., Mechanism of intracellular allosteric beta 2AR antagonist revealed by X-ray crystal structure. Nature (2017)

Release Date

2017-08-16

Peptides

Chimera protein of Beta-2 adrenergic receptor and Lysozyme: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Chimera protein of Beta-2 adrenergic receptor and Lysozyme

Related Entries With Identical Sequence